SEROPREVALENCE OF VIRAL HEPATITIS A, B, C, AND E MARKERS IN UROLOGICAL PATIENTS

Authors

  • Andrei Galescu “Nicolae Testemiţanu” State University of Medicine and Pharmacy, Chișinău, Republic of Moldova
  • Octavian Sajin National Public Health Agency, Chișinău, Republic of Moldova https://orcid.org/0009-0008-5458-6955
  • Emil Ceban “Nicolae Testemiţanu” State University of Medicine and Pharmacy, Chișinău, Republic of Moldova
  • Constantin Spînu National Public Health Agency, Chișinău, Republic of Moldova
  • Maria Isac National Public Health Agency, Chișinău, Republic of Moldova
  • Valentina Blaj National Public Health Agency, Chișinău, Republic of Moldova
  • Nina Izumov National Public Health Agency, Chișinău, Republic of Moldova
  • Mihaela Ivanov “Nicolae Testemiţanu” State University of Medicine and Pharmacy, Chișinău, Republic of Moldova https://orcid.org/0000-0002-5990-320X
  • Iurie Arian “Nicolae Testemiţanu” State University of Medicine and Pharmacy, Chișinău, Republic of Moldova https://orcid.org/0000-0003-1436-5230

DOI:

https://doi.org/10.5281/zenodo.8213208

Keywords:

seroprevalence, markers, viral hepatitis, urological patients

Abstract

Objectives. Emphasizing the importance of periodic testing for viral hepatitis markers in urology patients as a crucial measure for proper infection management.

Methods. A cross-sectional descriptive epidemiological study was conducted. Blood samples were collected from patients in the urology department of the Republican Clinical Hospital and examined using enzyme-linked immunosorbent assay (ELISA) for the following viral hepatitis markers: anti-HAV, anti-HAV IgM, AgHBs, anti-HBcor, anti-HBs, anti-HCV, anti-HEV IgG and anti-HEV IgM. A total of 234 patients were examined, and 1638 laboratory tests were performed.

Results. The following seroprevalence levels of viral hepatitis markers were identified among patients in the urology department of”Timofei Moșneaga” Republican Clinical Hospital: AgHBs – 9.0±1.9%; anti-HBcor –47.9±3.3%; anti-HBs – 41.0±3.2%; anti-HCV – 7.7±1.7%; anti-HAV – 95.3±1.4%; anti-HAV IgM – 0%; anti-HEV IgG – 17.5±2.5%; anti-HEV IgM – 27.4±2.9%. The most affected groups for hepatitis B and C were females from the central region of the country, while for hepatitis E – males from the northern region were the most affected.

Conclusions. The results indicate that urological patients can be considered a group at increased risk of infection with hepatitis B, C, and E viruses.

Published

04-08-2023

Issue

Section

SCIENTIFIC STUDIES

Similar Articles

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

1 2 > >>